Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Clarus Therapeutics Holdings, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Amory John Kenneth (Director) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Granted 1,922 shares
@ $0
Granted 4,805 options to buy
@ $0.4339, valued at
$2.1k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2022 |
4
| Hernandez Joseph (Director) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Disposed of 65,000 shares
@ $0
Acquired 1,237,500 shares
@ $0
Granted 3,445,000 warrants
@ $11.5, valued at
$39.6M
|
|
| 12/14/2021 |
4
| PRYGOCKI MARK A SR (Director) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Granted 3,844 shares
@ $0
Granted 9,610 options to buy
@ $4.78, valued at
$45.9k
|
|
| 12/14/2021 |
4
| Jaeger Frank (Chief Commercial Officer) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Granted 29,000 shares
@ $0
Granted 72,500 options to buy
@ $4.78, valued at
$346.6k
|
|
| 12/14/2021 |
4
| Cermak Elizabeth (Director) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Granted 3,844 shares
@ $0
Granted 9,610 options to buy
@ $4.78, valued at
$45.9k
|
|
| 12/14/2021 |
4
| Amory John Kenneth (Director) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Granted 3,844 shares
@ $0
Granted 9,610 options to buy
@ $4.78, valued at
$45.9k
|
|
| 12/14/2021 |
4
| Dudley Robert E. (CEO) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Granted 135,000 shares
@ $0
Granted 337,500 options to buy
@ $4.78, valued at
$1.6M
|
|
| 12/14/2021 |
4
| Hernandez Joseph (Director) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Granted 3,844 shares
@ $0
Granted 9,610 options to buy
@ $4.78, valued at
$45.9k
|
|
| 12/14/2021 |
4
| PETERSON RICHARD D (CFO) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Granted 55,800 shares
@ $0
Granted 139,500 options to buy
@ $4.78, valued at
$666.8k
|
|
| 12/14/2021 |
4
| Bourne Steven A. (Chief Administrative Officer) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Granted 29,000 shares
@ $0
Granted 72,500 options to buy
@ $4.78, valued at
$346.6k
|
|
| 12/14/2021 |
4
| Murphy Kimberly M (Director) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Granted 3,844 shares
@ $0
Granted 9,610 options to buy
@ $4.78, valued at
$45.9k
|
|
| 10/04/2021 |
4
| H.I.G. Ventures - Clarus, LLC (10% Owner) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Granted 490,531 shares
@ $0
Granted 2,731,094 shares
@ $0
Granted 2,470,756 shares
@ $0 |
|
| 09/21/2021 |
4
| FFI FUND LTD (10% Owner) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Sold 127,360 shares
@ $9.2, valued at
$1.2M
|
|
| 09/13/2021 |
4
| Zisson Alex (10% Owner) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Granted 490,531 shares
@ $0
Granted 2,731,094 shares
@ $0
Granted 2,470,756 shares
@ $0 |
|
| 09/13/2021 |
4
| Dudley Robert E. (CEO) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Granted 4,566 shares
@ $0 |
|
| 09/13/2021 |
4
| Bourne Steven A. (Chief Administrative Officer) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Granted 1,305 shares
@ $0 |
|
|
|